August 23, 2016 — Sage Products is expanding a recall for incontinence wipes that may be contaminated with the antibiotic-resistant bacteria B. cepacia.
On August 1, one lot of Comfort Shield® Barrier Cream Cloths were recalled after a product tested positive for B. cepacia.
On August 19, hundreds of lots of incontinence wipes were added to the recall. These products were distributed worldwide from August 2012 through August 2014. No infections have been reported.
B. cepacia infections can potentially cause severe, life-threatening infections — especially in hospitalized patients with weak immune systems.
The recalled products include:
- Comfort Shield Barrier Cream Cloths
- Incontinence Clean-Up Cloth
- M-care™ Meatal Cleansing Cloths for the Foley Catheterized Patient
- Comfort Bath® Cleansing Washcloths
- 2% Chlorhexidine Gluconate Cloths
B. cepacia, also known as “B. cepacia complex,” is a bacteria commonly found in soil and water. It mostly infects very sick patients in hospitals. Treatment is complex because it resists antibiotics.
Earlier this month, Diocto Liquid Stool Softener was recalled after 60 people were infected with B. cepacia in 8 states.
In recent years, several outbreaks of B. cepacia have also been linked to antiseptic wipes and baby wipes. In 2014, a class action lawsuit was filed against Wal-Mart after Simply Right Baby Wipes were recalled.
Do I have a B. Cepacia Lawsuit?
The Schmidt Firm, PLLC is currently accepting disposable wipe induced injury cases in all 50 states. If you or somebody you know has been infected with B. cepacia, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Product Liability Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.